SkinMedica Inc v. Histogen Inc, No. 12-1560 (Fed. Cir. Aug. 23, 2013)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

SkinMedica, Inc. ( “SkinMedica”) appeals from the d e- cision of the United States District Court for the Southern District of California granting Histogen, Inc., Histogen Aesthetics, and Gail Naughton (collectively “Histogen”) summary judgment of noninfringement of the asserted claims of U.S. Patent Nos. 6,372,494 ( ’494 patent) and 7,118,746 (’746 patent) after construing a phrase common to both patents. Because we find no legal error in the district court’s construction, we affirm the grant of su m- mary judgment. I.